NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Angiogenesis



New angiogenesis research from United Arab Emirates University discussed



February 24th, 2009

"Salmonella enterica serovar Typhimurium (hereafter S. typhimurium) stains have been shown to exert a potent inhibitory effect on the growth of human and mouse tumors in experimental models. Our laboratory has previously demonstrated that an attenuated strain of S. typhimurium engineered to express IL2 (designated strain GIDIL2) has demonstrable immunopotentiating properties, particularly affecting the innate arm of the immune system," researchers in Al Ain, United Arab Emirates report.

"In the present study, we wished to explore the properties of IL-2-expressing Salmonella as an oncotytic agent in the highly tumorigenic B16F1 melanoma mouse model and shed light on its...


Source: Cancer Weekly (2009-02-24)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login